irritantmoderate risk

Ethylenediamine Dihydrochloride

A stabilizer with important cross-reactions to antihistamines and aminophylline

INCI: Ethylenediamine

CategoryIrritant
Risk Levelmoderate
Drug cross-reactionsEthylenediamine allergy cross-reacts with aminophylline (used in asthma), piperazine antihistamines (hydroxyzine, cetirizine), and some antifungal medications
Systemic flareAn important mechanism of systemic contact dermatitis — oral aminophylline or antihistamine can cause widespread dermatitis in someone sensitized to topical ethylenediamine
ACDS standardIncluded in the ACDS patch test series as a standard contact allergen with important drug allergy implications

Names to look for on labels

This ingredient may appear under any of these names in ingredient lists:

Ethylenediamine DihydrochlorideEthylenediamineEthylenediamineEDA1,2-Diaminoethane
🔍Check if YOUR products contain Ethylenediamine Dihydrochloride →

Commonly found in

Topical cream (some formulations)
Medications containing aminophylline

Possible Reactions

Allergic contact dermatitis from topical preparations
Systemic contact dermatitis when taking aminophylline (theophylline) or antihistamines
Urticaria or widespread dermatitis from drug exposure in sensitized individuals

What is Ethylenediamine Dihydrochloride?

Ethylenediamine Dihydrochloride (INCI: Ethylenediamine; chemical name: 1,2-Diaminoethane dihydrochloride; abbreviation: EDA) is a diamine compound used as a stabilizer in some topical pharmaceutical preparations. As a cosmetic/pharmaceutical ingredient, it is less common than it once was, having been removed from many older formulations when its allergenicity was recognized. However, it remains clinically important because of its cross-reaction pattern with systemically administered drugs.

Ethylenediamine is included in the ACDS standard patch test series not primarily because of its prevalence in current topical products, but because a positive result has important implications for the patient's response to certain oral and intravenous medications.

Why does Ethylenediamine cause reactions?

Ethylenediamine is a diamine with strong nucleophilic properties — its two amine groups readily react with electrophilic molecules in skin proteins, forming hapten conjugates that sensitize Langerhans cells and initiate Type IV delayed hypersensitivity.

The most clinically important consequence of ethylenediamine sensitization is cross-reactivity with structurally related compounds:

  • Aminophylline: A compound used in asthma and COPD treatment, aminophylline is an ethylenediamine-theophylline complex. Patients sensitized to ethylenediamine can develop systemic contact dermatitis — widespread generalized rash — when given aminophylline intravenously or orally
  • Piperazine antihistamines: Hydroxyzine (Atarax) and cetirizine (Zyrtec, Cetrizet) are piperazine derivatives that share structural similarity with ethylenediamine. Ethylenediamine-sensitized patients may react to these very commonly prescribed antihistamines — creating an ironic situation where the antihistamine prescribed to treat an itch causes an allergic reaction
  • Some antifungals: Certain imidazole antifungals have structural relationships that may cause cross-reactions in some patients

This systemic contact dermatitis mechanism — where skin sensitization to a contact allergen leads to a systemic drug reaction when the allergen or a cross-reactive compound is taken orally or intravenously — is a classic and important clinical concept.

Where is Ethylenediamine found in products?

In cosmetics and topical pharmaceuticals, ethylenediamine now appears infrequently (it has been removed from many formulations). It may still be present in:

  • Some older formulation topical creams: Used as a pH stabilizer
  • Some ophthalmic preparations: As a stabilizing agent

How to spot Ethylenediamine on labels

  • Ethylenediamine — INCI and INN name
  • Ethylenediamine Dihydrochloride — salt form used in topicals
  • 1,2-Diaminoethane — IUPAC name

On pharmaceutical drug labels: may appear in inactive ingredients.

In Indian products 🇮🇳

Ethylenediamine is more significant in India for its drug cross-reactivity implications than for its prevalence in current topical products. Cetirizine (available OTC in India as Zyrtec, Cetrizet, and numerous generics) is one of the most widely used antihistamines in India. Hydroxyzine is prescribed for anxiety and itch. The cross-reactivity between ethylenediamine and these piperazine antihistamines means that an Indian patient who has been sensitized to ethylenediamine (from an older topical preparation) could experience a widespread reaction when given a commonly prescribed antihistamine.

Indian patients with confirmed ethylenediamine allergy should inform all their healthcare providers — dermatologists, general practitioners, and allergists — about this allergy and the need to avoid piperazine-class antihistamines and aminophylline-containing asthma medications.

Safer alternatives

  • Non-piperazine antihistamines: For antihistamine use in ethylenediamine-allergic patients — loratadine, fexofenadine, desloratadine (all second-generation, non-piperazine), and diphenhydramine (first-generation, non-piperazine) are alternatives
  • Theophylline without ethylenediamine: Plain theophylline (without the ethylenediamine carrier of aminophylline) may be better tolerated — discuss with prescribing physician
  • Ethylenediamine-free topical formulations: Modern topical preparations generally no longer contain ethylenediamine as a stabilizer

Is this ingredient in your products?

Scan any cosmetic product to check for Ethylenediamine Dihydrochloride and 30+ other allergens instantly.